When Should You Start Saving for Retirement?
There's an old saying about investing that applies, almost word for word, to hormone optimization.
The best time to start saving for retirement was thirty years ago. The second best time is today.
I didn't invent that parallel, but after 25 years as a compounding pharmacist and a decade of teaching women about hormones, I can tell you it holds up. If you went into menopause at 50 and did nothing for your hormones until now . . . that's a long time without estradiol, and it has consequences. The question is not whether there are consequences. The question is what to do about it, whether it's too late to do anything at all, and what "something" even looks like at this point.
My answer: it's almost never too late. But the picture does get more complicated the longer you wait. Let me explain what I mean by that.
What You Got If You Started HRT Right After Menopause
If you started hormone replacement therapy around age 50 or 51, right after your periods stopped, you would have experienced two categories of benefits.
The obvious ones: relief from symptoms. Hot flashes, night sweats, insomnia, mood swings, vaginal dryness, brain fog. Not every woman gets complete relief, and not every doctor helps women optimize fully, but the symptom picture tends to improve.
Then there are what I call the invisible benefits. These are the ones that don't show up in how you feel day to day, but that are quietly protecting your health over the long term.
Bone strength. Estradiol is the primary protector of bone density in women. Without it, bone loss accelerates, and the effects compound over decades. Starting HRT at 50 means you've been protecting your bones throughout the highest-risk window for osteoporosis.
Cardiovascular health. Estrogen maintains the elasticity of your blood vessels and keeps lipid markers, including ApoB, at levels that work in your favor rather than against you. The cardiovascular protection of early HRT is one of the most consistent findings across decades of research.
Vaginal and urinary tissue. Estrogen keeps these tissues healthy, elastic, and resistant to chronic irritation and infection. Without it, the atrophy is progressive and, left untreated, uncomfortable in ways that affect daily quality of life.
Memory and cognitive function. Multiple observational studies link early estrogen use to lower dementia risk. The connection is complex, and I won't overstate it, but the signal is consistent.
Insulin sensitivity. Estrogen helps regulate how your body handles glucose and insulin. This has downstream effects on weight, cardiovascular health, and long-term metabolic function.
These are the benefits a woman who started HRT at 50 has been quietly accumulating, often without realizing it, for a decade or more.
What Changes When You Wait
If you didn't start HRT at 50 and you're now 60, or 65, or older . . . the obvious benefits are still available to you. The symptom relief side of the equation doesn't change much with time. If you're still having hot flashes or night sweats at 62, estradiol can still help. If your sleep is wrecked, progesterone can still help.
The invisible benefits are where the picture gets more complicated. And here's why: going ten years or more without hormones causes some degree of invisible damage, and that damage varies enormously from one woman to the next.
Some women at 60 have excellent bone density, clean cardiovascular markers, and no sign of the metabolic drift that estrogen loss drives. Others have developed osteopenia or full osteoporosis, rising ApoB and LDL levels, insulin resistance, or early signs of cardiovascular disease. The same elapsed time, very different outcomes, because every woman's biology, genetics, lifestyle, and stress load are different.
A friend of mine and my wife's is one of the women who looks like she beat the clock. She exercises constantly, eats an extremely clean diet, does yoga and HIIT training. She really hasn't changed much in twenty years. She looks healthy, slim, and vibrant. But at 60, she started seeing serious bone density problems and cardiovascular risk factors she simply could not fix with more exercise or a better diet. The invisible damage was there, even in a woman doing everything right.
That's the honest reality of going a decade without hormones. You can't always see the accumulation from the outside.
The WHI Question
When people ask about starting HRT later in life, the Women's Health Initiative (WHI) usually comes up. The WHI is the study from 2002 that scared a generation of women and doctors away from hormones, and it showed elevated risks for a subset of women on a specific hormone regimen.
Here is what the WHI actually studied: women with an average age of 63, meaning they were, on average, more than ten years past menopause when the study began. And they were not a particularly healthy group. The study itself reports that 69% were overweight or obese, 50% were past or current smokers, 35% had been treated for high blood pressure, and 12.5% had cholesterol high enough to require medication.
These are not women who recently went into menopause and were asking whether to start HRT. These are women who had been without hormones for a decade or more, during which time their cardiovascular health had deteriorated in ways that placed them at elevated baseline risk, and then they were given oral conjugated equine estrogens combined with a synthetic progestin.
For a full explanation of how the WHI's findings have been reinterpreted and why the FDA's own black box warning on HRT was removed in November 2025, see my post on the FDA's black box warning.
The WHI actually confirmed something important: women who go without hormones for a decade don't just stay neutral. They accumulate cardiovascular and metabolic changes that increase their baseline risk. Starting hormones at that point is a different clinical scenario than starting at 50, when the cardiovascular system is still in good shape.
The Specific Risk: Plaques
Here is the most important nuance for women who are ten or more years past menopause and considering HRT for the first time.
Over time, without estrogen's protective effect on blood vessel walls, plaques can develop. Plaques are deposits of cholesterol, calcium, and other material that build up inside arterial walls. In a healthy cardiovascular system, starting HRT is associated with reduced cardiovascular events. But in a cardiovascular system where plaques have already formed, starting systemic hormone therapy can, in some circumstances, cause instability that increases short-term risk.
This is not a reason to say no automatically. It is a reason to find out whether you personally have that risk, because the answer varies significantly from woman to woman.
Does every woman who skipped hormones for ten years have meaningful plaque burden? No. Some do, and some don't. The only way to know is a proper cardiovascular workup, which may include things like a coronary artery calcium (CAC) score, lipid panel, or assessment of other cardiovascular risk factors.
A woman without significant cardiovascular risk who starts HRT at 62 is a very different clinical situation from a woman with advanced arterial disease who starts at 62. Applying the same blanket decision to both of them is not good medicine.
What You Can Still Get
Even for women who have been without hormones for a long time, there is meaningful benefit to be gained from hormone therapy, often substantial benefit, depending on where their health is starting from.
Bone protection. It is not too late to slow or stop bone loss. Even women with established osteopenia can stabilize and in some cases improve bone density with HRT, though the earlier you start, the more bone you protect.
Symptom relief. If you're still having hot flashes, sleep disruption, mood changes, or cognitive fog, the treatment that addresses the root cause is still available. Symptoms don't have an expiration date.
Genitourinary health. Low-dose vaginal estradiol is appropriate for virtually all women regardless of when they last had systemic HRT, and even for most women who aren't candidates for systemic therapy. If you have vaginal dryness, painful intercourse, or recurrent urinary tract infections, this intervention is evidence-based and has a very favorable safety profile. It does not carry the same considerations as systemic estrogen.
Metabolic and cardiovascular support. For women without significant pre-existing cardiovascular disease, HRT can still improve lipid profiles, insulin sensitivity, and metabolic markers. The magnitude of benefit may be smaller than it would have been if started at 50, but it is not zero.
The range of what's available to you is wide. What's actually appropriate depends on where your health is right now.
If you're past menopause and you never started HRT: The fact that time has passed does not close the door. It does mean you need someone who actually knows what they're doing. The Menopause Solution is my 7-step course covering the full landscape of what the evidence says, what the options are, and how to have this conversation with a provider who will actually listen.
Why Most Doctors Will Probably Still Say No
If you go to your primary care physician or OB/GYN and say "I'm 62 and I've never taken HRT, can I start now?" there's a very good chance the answer will be no.
That no is not necessarily based on a careful evaluation of your specific situation. It is often based on general caution carried over from the post-WHI era, combined with the reality that most physicians do not have deep training in hormone optimization and are not eager to wade into a complex assessment they don't feel equipped to run.
I understand that. Genuinely evaluating whether a woman ten or more years past menopause is a good candidate for HRT requires looking at her heart status, her bone density, her metabolic markers, her symptom burden, her goals, and the full range of available options, including systemic vs. local therapy, different routes and formulations, and different risk-reduction approaches. It takes time and expertise.
A hormone optimization specialist, someone with the specific training to navigate exactly this scenario, is the right person for this conversation. That's not me dismissing your current provider. It's acknowledging that this is a subspecialty, the same way you'd see a retinal specialist for a serious eye issue rather than asking your internist to manage it.
For thoughts on what individualized assessment looks like across a broader age range, see my post on HRT over 65.
What to Do If You're in This Situation
The first step is finding a provider who actually has the training to assess where you are and what's appropriate for you. I maintain a referral list of hormone optimization specialists across the country. If you're looking for someone who can run a proper evaluation, that's the place to start: simplehormones.com/referral.
When you get to that appointment, the conversation should include:
A cardiovascular risk assessment. Not just "do you have any history of heart disease," but a real look at where your cardiovascular system actually is right now.
On the blood work side, that includes:
- comprehensive lipid panel (with ApoB, not just standard cholesterol numbers)
- metabolic panel that includes markers for insulin resistance
- inflammation panel that includes markers like high sensitivity C-reactive protein
For women with a longer window since menopause or additional risk factors, some specialists will also order imaging, such as:
- coronary artery calcium (CAC) scan, which quantifies calcified plaque in the arteries
- carotid intima-media thickness (CIMT) study, which measures arterial wall changes as an early cardiovascular signal
- stress test may come into play if there are functional concerns
- coronary angiogram is generally reserved for women with actual cardiac symptoms
Not every woman will need all of these, but a thorough evaluation uses the right tools to answer the right question: does this specific woman have arterial changes that would make starting systemic hormones a different conversation, and if so, what's the best path forward?
Bone density data. A DEXA scan if you don't have a recent one. The results change the conversation about urgency.
A clear picture of your symptoms. Which ones are still active, how much they're affecting your daily life, and what your priorities are.
A review of all your options. Systemic vs. local, oral vs. transdermal, estrogen alone vs. combined therapy, whether or not you have a uterus. The answer is not the same for every woman.
This assessment is more work than a blanket "you're too old." It's also the only kind of medicine that can actually answer the question honestly.
The Bottom Line
Is it too late to start HRT? Almost certainly not, but the honest answer depends on you specifically.
If you went into menopause at 50 and you're 62 now, you've spent twelve years without hormones. Some things have shifted. Some of those shifts can be addressed. Some require more careful navigation than they would have at 50. A good hormone specialist can help you figure out which category you're in and what the options are.
What I can tell you is that "it's been too long, so no" is not a complete medical answer. It's a shortcut. And the women I see who get that shortcut are often women who could genuinely benefit from a more careful, individualized conversation.
The second best time to start is now.
A Note on This Post
I'm a pharmacist, not a physician. Nothing in this post is personal medical advice. This is educational content intended to help you have more informed conversations with your healthcare provider. Decisions about starting or restarting HRT should be made with a knowledgeable provider who has access to your full health history.
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. doi:10.1001/jama.288.3.321. (Original WHI publication; study population had average age 63, 69% overweight/obese, 50% past or present smokers, 35% previously treated for high BP, 12.5% on lipid-lowering medication.)
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. doi:10.1001/jama.2013.278040. (Long-term WHI follow-up; estrogen-alone showed reduced breast cancer risk and neutral-to-favorable cardiovascular outcomes in women who started closer to menopause.)
- Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221-1231. doi:10.1056/NEJMoa1505241. (ELITE trial: estradiol slowed subclinical atherosclerosis progression in women who started within 6 years of menopause but not in women who started 10 or more years post-menopause — the foundational "timing hypothesis" study.)
- Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol. 2017;13(4):220-231. doi:10.1038/nrendo.2016.164. (Comprehensive review of the timing hypothesis — early initiation favorable for cardiovascular outcomes; late initiation requires individual assessment.)
- U.S. Food and Drug Administration. HHS Advances Women's Health: Removes Misleading FDA Warnings on Hormone Replacement Therapy. November 10, 2025. fda.gov. (FDA removal of cardiovascular, breast cancer, and dementia language from HRT boxed warnings.)
- Baik SH, Baye F, McDonald CJ. Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses. Menopause. 2024;31(5):362-371. doi:10.1097/GME.0000000000002335. (10M+ Medicare women over 65; estrogen monotherapy associated with 19% reduction in all-cause mortality and reductions in multiple disease endpoints — directly relevant to late-start timing question.)
